NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. The phase 3 ...

Shares of NewAmsterdam Pharma rose in premarket trading Monday after finding positive benefits for treating Alzheimer's Disease in its cholesterol drug study. Shares traded 9.2% higher ahead of the ...

Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both ...

Examining blood lipid levels may help physicians predict a patient’s risk of developing Alzheimer’s disease, according to a study published May 30 in Neurology.  Here are five notes on the study: Read ...

A person aged 75 to 80 is less likely to have dementia today compared to someone of the same age several decades ago, a ...

The new review of Alzheimer’s disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs.

“Things like having a healthy diet, exercising regularly, limiting the amount of alcohol you drink, not smoking, keeping your ...

A person aged 75 to 80 is less likely to have dementia today compared to someone of the same age several decades ago, a ...

New dementia diagnoses have significantly decreased since 2015, a study published in BMJ found.But more people are living ...

By contrast, regions such as the Pacific Northwest, the Great Plains, and the Rocky Mountains showed much lower connections ...

Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer's disease biomarker in both ...